Status: Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.
Participants needed: 663
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: EmStop IncUpdated: Jun 26, 2026Locations: 3
Eligibility criteria
Meets FDA-approved indications for elective transfemoral self-expanding transcat... [+13]
Requires use of a balloon-expandable transcatheter aortic valve for the index pr... [+16]